当前位置:
X-MOL 学术
›
J. Am. Chem. Soc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Chemically-defined antibody- and small molecule-drug conjugates for in vivo tumor targeting applications: a comparative analysis
Journal of the American Chemical Society ( IF 14.4 ) Pub Date : 2018-01-27 , DOI: 10.1021/jacs.7b13361 Samuele Cazzamalli 1 , Alberto Dal Corso 1 , Fontaine Widmayer 1 , Dario Neri 1
Journal of the American Chemical Society ( IF 14.4 ) Pub Date : 2018-01-27 , DOI: 10.1021/jacs.7b13361 Samuele Cazzamalli 1 , Alberto Dal Corso 1 , Fontaine Widmayer 1 , Dario Neri 1
Affiliation
We present the first direct comparative evaluation of an antibody-drug conjugate and of a small molecule-drug conjugate for cancer therapy, using chemically defined products which bind with high-affinity to carbonic anhydrase IX, a marker of tumor hypoxia and of renal cell carcinoma.
中文翻译:
用于体内肿瘤靶向应用的化学定义的抗体和小分子药物缀合物:比较分析
我们首次对用于癌症治疗的抗体-药物偶联物和小分子-药物偶联物进行直接比较评估,使用化学成分确定的产品,这些产品与碳酸酐酶 IX(肿瘤缺氧和肾细胞癌的标志物)具有高亲和力结合。
更新日期:2018-01-27
中文翻译:
用于体内肿瘤靶向应用的化学定义的抗体和小分子药物缀合物:比较分析
我们首次对用于癌症治疗的抗体-药物偶联物和小分子-药物偶联物进行直接比较评估,使用化学成分确定的产品,这些产品与碳酸酐酶 IX(肿瘤缺氧和肾细胞癌的标志物)具有高亲和力结合。